depomed inc (DEPO:NASDAQ GS)
James A. Schoeneck
Chief Executive Officer, President and Director, DepoMed Inc.
|Age||Total Calculated Compensation||This person is connected to 16 board members in 2 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. James A. Schoeneck, also known as Jim has been the Chief Executive Officer and President of DepoMed Inc., since April 18, 2014. Mr. Schoeneck serves as a Strategic Advisor to Kreido Laboratories. He served as the Chief Executive Officer of BrainCells Inc. since October 2005. Mr. Schoeneck served as Chief Executive Officer of ActivX Biosciences Inc., from November 2003 to December 2004. Mr. Schoeneck served as President and Chief Executive Officer of Prometheus Laboratories ...
7999 Gateway BoulevardPhone: 510-744-8000
Newark, California 94560
Board Members Memberships*
Chief Executive Officer, President and Director
Non-Employee Director, Chairman of Compensation Committee and Member of Audit Committee
Jacksonville State University
|Ron Cohen M.D.||Founder, Chief Executive Officer, President and Director|
Acorda Therapeutics, Inc.
|Howard W. Robin||Chief Executive Officer, President and Director|
|Jack A. Khattar||Founder, Chief Executive Officer, President, Secretary and Director|
Supernus Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$889.2K||Compensation as of Fiscal Year 2014.|